Who is eligible for TIL therapy for melanoma?

This video is from the Animated Patient's Guide to Melanoma www.YouAndMela..., developed by the Melanoma Research Foundation (MRF) and Mechanisms in Medicine Inc.
The mission of the Melanoma Research Foundation is to eradicate melanoma by accelerating medical RESEARCH while EDUCATING to and ADVOCATING for the melanoma community. To learn more about the MRF visit melanoma.org.
Connect with the MRF online:
► Facebook: / melanoma.research.foun...
► Twitter: / curemelanoma
► Instagram: / curemelanoma
► RUclips: / curemelanoma
► LinkedIn: / melanoma-research-foun...
------------------------------------------------------------------------------------------------
Video description:
Rekha Chaudhary, MD, a hematologist and oncologist who specializes in the treatment of melanoma at the University of Cincinnati, explains some of the important criteria that make a melanoma patient eligible for tumor infiltrating lymphocyte (TIL) therapy. Patients need a tumor large enough and accessible enough to biopsy for TIL therapy. They also need to be healthy enough to undergo the chemotherapy, or lymphodepletion, as well as the IL-2 infusions to receive the TIL therapy.